Cite
Gaziano JM, Cincotta AH, O'Connor CM, et al. Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes. Diabetes Care. 2016;39(10):1846doi: 10.2337/dc16-er10.
Gaziano, J. M., Cincotta, A. H., O'Connor, C. M., Ezrokhi, M., Rutty, D., Ma, Z. J., & Scranton, R. E. (2016). Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes. Diabetes care, 39(10), 1846. https://doi.org/10.2337/dc16-er10
Gaziano, J Michael, et al. "Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes." Diabetes care vol. 39,10 (2016): 1846. doi: https://doi.org/10.2337/dc16-er10
Gaziano JM, Cincotta AH, O'Connor CM, Ezrokhi M, Rutty D, Ma ZJ, Scranton RE. Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes. Diabetes Care. 2016 Oct;39(10):1846. doi: 10.2337/dc16-er10. PMID: 27660123; PMCID: PMC6908412.
Copy
Download .nbib